• Praxis Precision Medicines will report third-quarter 2026 financial results before markets open Nov. 9, 2026.
• Investor Day in New York starts Nov. 12, 2026, at 8 a.m. ET, covering commercial strategy, launch readiness and pipeline updates.
• A Guggenheim Securities Inaugural Healthcare Innovation Conference fireside chat takes place Nov. 9, 2026, at 9:30 a.m. ET in Boston.
• The UBS Global Biopharma Conference fireside chat is scheduled for Nov. 16, 2026, at 5:40 a.m. ET/10:40 a.m. GMT in London.
• Senior management will hold investor one-on-one meetings at the Jefferies Global Healthcare Conference in London Nov. 17–18, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Praxis Precision Medicines Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610271601PRIMZONEFULLFEED9854335) on October 27, 2026, and is solely responsible for the information contained therein.